A Study to Evaluate the Efficacy and Safety of DC-806 in Participants With Moderate to Severe Plaque Psoriasis
Completed · Phase 2 · Has a placebo group
Conditions studied: Plaque Psoriasis
In brief
This was a 12-week treatment, multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging study to evaluate the efficacy and safety of DC-806 in participants with moderate to severe plaque psoriasis. This study evaluated the efficacy, safety, tolerability, and pharmacokinetics (PK) of multiple oral doses of DC-806 in participants with moderate to severe plaque psoriasis.
Key facts
- Study ID
- NCT05896527
- Run by
- DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company
- People needed
- 229
- Starts
- 2023-05-02
- Expected to finish
- 2024-03-25
- Last updated by the study team
- 2025-04-04
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
Where it is running
- First OC Dermatology — Fountain Valley, California, United States
- Clinical Science Institute — Santa Monica, California, United States
- Driven Research LLC — Coral Gables, Florida, United States
- Kirsch Dermatology - Probity - PPDS — Naples, Florida, United States
- GCP Global Clinical Professionals, LLC — St. Petersburg, Florida, United States
- ForCare Clinical Research - CenExel FCR - PPDS — Tampa, Florida, United States
- The Indiana Clinical Trials Center, PC — Plainfield, Indiana, United States
- Dermatology Specialists Research - 501 S 2nd St — Louisville, Kentucky, United States
- DICE Therapeutics Study Site — New York, New York, United States
- Dermatologists of Southwest Ohio - Probity - PPDS — Mason, Ohio, United States
- Paddington Testing Company Inc — Philadelphia, Pennsylvania, United States
- Center for Clinical Studies - Webster — Webster, Texas, United States
- Virginia Clinical Research Inc — Norfolk, Virginia, United States
- Alberta DermaSurgery Centre - Probity - PPDS — Edmonton, Alberta, Canada
- Enverus Medical Research - Probity - PPDS — Surrey, British Columbia, Canada
- Wiseman Dermatology Research Inc. - Probity - PPDS — Winnipeg, Manitoba, Canada
- CCA Medical Research - Probity - PPDS — Ajax, Ontario, Canada
- SimcoDerm Medical and Surgical Dermatology Centre - Probity - PPDS — Barrie, Ontario, Canada
- Dermatrials Research — Hamilton, Ontario, Canada
- Lynderm Research Inc. - Probity - PPDS — Markham, Ontario, Canada
- DermEdge Research Probity - PPDS — Mississauga, Ontario, Canada
- DICE Therapeutics Study Site — North York, Ontario, Canada
- Alliance Clinical Trials - Probity - PPDS — Waterloo, Ontario, Canada
- Centre de Recherche Dermatologique du Quebec metropolitain (CRDQ) — Québec, Canada
- DICE Therapeutics Study Site — Lübeck, Germany
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.